Lexeo Therapeutics Inc.
LXEO
Get informed when a big investor buys or sells
+ FollowMarket Cap$253.62M
Close$
$1.03
61.1% downside
Current Fair Value
61.1% downsideOvervalued by 61.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $253.62 Million |
|---|---|
| Enterprise Value | $167.60 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.86 |
| Beta | 1.64 |
| Outstanding Shares | 85,626,751 |
Return
| Return on Equity | -37.12% |
|---|---|
| Return on Assets | -34.24% |
| Return on Invested Capital | 12.85% |
Valuation & Multiples
| P/E Ratio | -2.81 |
|---|---|
| PEG | 310.66 |
| Price to Sales | - |
| Price to Book Ratio | 1.32 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 5.45 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
December 14, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.1585▲ 300.73% |
|---|---|
| Total Calls | 16,400▼ 75.19% |
| Total Puts | 51,800▲ 418.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 103.26%▲ 4.85% |
|---|---|
| Total Invested | $411.70M▼ 10.25% |
| Investors Holding | 146▲ 3.00% |
ESG Score
No data